| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655622 | Digestive and Liver Disease | 2017 | 23 Pages |
Abstract
CD patients on conventional therapy showed a lower FFM and a lower mean phase angle score compared to those on infliximab therapy. Following infliximab treatment the mean phase angle score normalized. PhA is a reliable nutritional indicator in IBD patients and could be considered as an additional tool for assessing response to treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Sara Emerenziani, Livia Biancone, Michele Pier Luca Guarino, Paola Balestrieri, Elisa Stasi, Mentore Ribolsi, Maria Paola Rescio, Annamaria Altomare, Silvia Cocca, Francesco Pallone, Michele Cicala,